DRIODarioHealth Corp.vs its industry peers
A metric-by-metric comparison of DarioHealth Corp. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRIO본 종목 | $30M#2 | 0.6x#2 | 0.5x#2 | 1.3x#3 | -17.3%#5 | 2.4%#2 | -163.9%#3 | -75.7%#4 | -41.6%#3 | 3#4 | -81.3%#1 | — |
| XAIR | $2M#5 | 0.2x#1 | 1.2x#4 | 0.3x#1 | 107.3%#1 | -29.2%#5 | -378.2%#5 | 1.7%#2 | -347.6%#4 | 6#2 | -94.0%#3 | — |
| NEPH | $35M#1 | 20.4x#3 | 4.2x#5 | 1.9x#4 | 32.7%#2 | 1513.5%#1 | 6.1%#1 | 14.3%#1 | 26.8%#1 | 7#1 | — | — |
| AMIX | $2M#6 | — | 0.6x#3 | — | — | -46.5%#6 | — | -528.6%#5 | -743.5%#6 | — | — | — |
| PMI | $21M#3 | — | 12.2x#6 | 4.3x#5 | 12.5%#4 | -28.2%#4 | -268.4%#4 | -1573.5%#6 | -495.0%#5 | — | -93.7%#2 | — |
| RVP | $17M#4 | — | 0.2x#1 | 0.5x#2 | 15.8%#3 | -5.7%#3 | -55.3%#2 | -17.2%#3 | -29.7%#2 | 5#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice